Interleukin-18 (IL-18), a pro-inflammatory cytokine belonging to the interleukin-1 (IL-1) family, is involved in the pathogenesis of autoimmune/ autoinflammatory and allergic diseases such as juvenile idiopathic arthritis and bronchial asthma. IL-18 forms a signalling complex with the IL-18 receptor (IL-18R) and (IL-18R) chains; however, the detailed activation mechanism remains unclear. Here, the IL-18-IL-18R binary and IL-18-IL-18R-IL-18R ternary complexes were purified and crystallized as well as IL-18 alone. An X-ray diffraction data set for IL-18 was collected to 2.33 Å resolution from a crystal belonging to space group P2 1 , with unit-cell parameters a = 68.15, b = 79.51, c = 73.46 Å , = 100.97 . Crystals of both the IL-18 binary and ternary complexes belonging to the orthorhombic space groups P2 1 2 1 2 and P2 1 2 1 2 1 , respectively, diffracted to 3.10 Å resolution. Unit-cell parameters were determined as a = 135.49, b = 174.81, c = 183.40 Å for the binary complex and a = 72.56, b = 111.56, c = 134.57 Å for the ternary complex.
Introduction
IL-18 is a pro-inflammatory cytokine that was first identified as an interferon-(IFN-)-inducing factor in the sera of endotoxininjected mice (Okamura et al., 1995) . IL-18 not only plays an important role in host defence against microorganisms, but also contributes to the pathogenesis of autoimmune/autoinflammatory and allergic diseases (Nakanishi et al., 2010) such as juvenile idiopathic arthritis (Lotito et al., 2007) , familial Mediterranean fever (Simsek et al., 2007) , cryopyrin-associated periodic syndrome (Ohnishi et al., 2012) , bronchial asthma (Tanaka et al., 2001) and atopic dermatitis . IL-18 is expressed by various cell types including macrophages, keratinocytes and osteoblasts (Lorey et al., 2004) and belongs to the IL-1 superfamily, sharing structural and functional properties with IL-1. IL-18 also shares the same signalling cascade with IL-1. The inflammatory cytokines or stimulants for Toll-like receptors activate intracellular NOD-like receptors such as NLRP3. Activated NLRP3 recruits adaptor protein ASC and caspase-1 precursor (pro-caspase-1); collectively, these proteins form a complex referred to as the inflammasome (Srinivasula et al., 2002) . Formation of the inflammasome leads to autocatalytic cleavage of pro-caspase-1, and activated caspase-1 subsequently maturates the IL-18 precursor, which is then secreted outside the cell. To initiate IL-18 intracellular signalling, mature IL-18 is required for the assembly of IL-18R and IL-18R. First IL-18 binds to IL-18R at the plasma membrane, and then IL-18R binds to the IL-18-IL-18R heterodimeric complex . Assembly of the extracellular region juxtaposes the intracellular Toll-IL-1 receptor (TIR) domains of IL-18R and IL-18R, which recruit the adapter molecule MyD88 and sequentially activate IRAKs, TRAF6 and finally NF-B (O'Neill & Greene, 1998) . This signalling cascade then up-regulates the expression of inflammatory cytokines such as IFN-. Increased serum levels of IL-18 are frequently correlated with the severity of the autoimmune and autoinflammatory diseases described above. Because of its critical role in mediating inflammatory immune responses in vivo, IL-18 is normally regulated via the naturally occurring IL-18-binding protein (IL-18BP). IL-18BP specifically binds to IL-18 with high affinity, with a dissociation constant of 0.4 nM, and prevents IL-18 recognition of IL-18R (Dinarello et al., 2013) , which is functionally analogous to inhibition of IL-1 signalling by the IL-1 decoy receptor (IL-1RII). Indeed, the potent ability of IL-18 to mediate severe chronic disease has attracted a great deal of interest in the development of new therapeutic reagents that target the IL-18 signalling pathway. However, the structural basis of the IL-18 signalling complex, which can dramatically promote the rational design of IL-18 inhibitory drugs, remains unclear. To this end, we purified and crystallized the IL-18-IL-18R binary and IL-18-IL-18R-IL-18R ternary complexes as well as the IL-18 monomer; here, we report the preliminary X-ray analysis of each protein.
Materials and methods
2.1. Cloning, expression and purification of IL-18, IL-18Ra and IL-18Rb IL-18 was overproduced with minor modification of the induction conditions and purified as described previously . Briefly, mature human IL-18 (residues 1-157) fused with a factor Xa recognition site at the N-terminus was cloned into the pGEX 4T-1 vector (GE Healthcare, Little Chalfont, England). IL-18 was expressed as a glutathione S-transferase (GST) fusion protein in Escherichia coli strain BL21(DE3) with 0.05 mM isopropyl -d-1thiogalactopyranoside. After GST affinity chromatography and removal of the GST tag by digestion with factor Xa, IL-18 was purified by gel-filtration column chromatography. The extracellular domains of human IL-18R (NM_003855, residues 20-329) or IL-18R (NM_003853, residues 15-356) were each cloned separately into the pFastBac1 baculovirus transfer vector (Invitrogen, Carlsbad, California, USA) with an N-terminal signal peptide sequence for Sf9 insect cells, an 8ÂHis tag and a human rhinovirus (HRV) 3C protease cleavage site. Firstly, the coding sequence of each extracellular domain was amplified by PCR with primers containing the signal peptide sequence (Table 1 ) and then ligated into the pFastBac1 vector between EcoRI and NotI restriction sites. Secondly, a DNA oligo (48 bp) encoding an 8ÂHis tag and an HRV 3C cleavage site was phosphorylated by T4 kinase (Toyobo, Osaka, Japan) and inserted into the linearized transfer vectors, which were prepared by PCR, using the blunt-end ligation method. Consequently, an 8ÂHis tag cleavable by HRV 3C protease was inserted before the coding sequences. IL-18R and IL-18R were expressed using the same protocol. The modified transfer vector was introduced into E. coli DH10Bac (Invitrogen) to generate bacmid DNA, which was transfected into Sf9 cells to generate recombinant baculovirus. The baculovirus was then amplified in two cycles. For IL-18 receptor production, Sf9 cell cultures at a density of 2 Â 10 6 cells ml À1 were infected with the recombinant baculovirus at a multiplicity of infection (m.o.i.) of 0.1 plaque-forming units (pfu) per cell. Baculovirusinfected Sf9 culture media were harvested after 72 h by centrifugation. The IL-18 receptors were each purified separately using the same chromatographic steps. The receptor secreted from Sf9 cells was collected with ion-exchange columns from the culture media, most impurities were removed using Q Sepharose (GE Healthcare) and the IL-18 receptor in the flowthrough was captured by SP Sepharose (GE Healthcare). After an extensive washing step with 50 mM sodium phosphate buffer pH 6.0 containing 50 mM sodium chloride, the IL-18 receptor was eluted from an SP Sepharose column with 50 mM sodium phosphate buffer pH 6.0 containing 500 mM sodium chloride. The pH of the eluate was then adjusted to 7.4 with sodium hydroxide solution and the 8ÂHis-tagged proteins were purified by Ni-NTA agarose (Qiagen, Venlo, Netherlands) chromatography with elution buffer containing an linear gradient of imidazole concentration from 150 to 250 mM. After digestion of the N-terminal 8ÂHis tag with HRV 3C protease, the receptor was further purified by sizeexclusion chromatography on an Superdex 75 26/60 column (GE Healthcare) with 20 mM sodium phosphate buffer pH 7.0 containing 150 mM sodium chloride and 0.1 mM ethylenediaminetetraacetic acid; the HRV 3C protease was removed in this step.
To obtain the IL-18-IL-18R binary and IL-18-IL-18R-IL-18R ternary complexes, IL-18, IL-18R and IL-18R were mixed in equimolar ratios and purified by gel-filtration chromatography on a Superdex 200 16/60 column with the same buffer as that used in the previous gel-filtration step. Protein elution was monitored at a wavelength of 280 nm. Moreover, we assessed the molecular weights of each protein or protein complex using analytical gel-filtration Table 1 Macromolecule-production information.
Amino acids shown in bold were removed after protease cleavage. 
column chromatography. The three proteins were mixed in all possible combinations and each sample was loaded onto a Superdex 200 10/300 GL column (GE Healthcare). Each sample was isocratically eluted at a flow rate of 0.25 ml min À1 in 50 mM sodium phosphate pH 7.0, 150 mM sodium chloride. The molecular masses were estimated using a calibration curve of gel-filtration standards (Bio-Rad, Hercules, California, USA).
Crystallization
Before crystallization, the protein samples were dialyzed against 5 mM HEPES-Na pH 7.0 containing 10 mM sodium chloride. Crystallization screening of IL-18 was conducted using the hanging-drop vapour-diffusion method in 24-well plates. Crystals were obtained using an ammonium sulfate-based screening kit (Hampton Research, McLean, Virginia, USA). Subsequently, the crystallization conditions were optimized by adding detergent: 400 nl of 7.0 mg ml À1 protein solution was mixed with 400 nl precipitant solution and 200 nl 0.25%(w/v) CHAPS (Dojindo, Kumamoto, Japan). This mixture was then equilibrated against 500 ml precipitant solution. Crystallization screening of the binary and ternary complexes was carried out using the sitting-drop vapour-diffusion method in 96-well plates, in which 100 nl protein solution was mixed with 100 nl of each precipitant solution. Crystals of the IL-18-IL-18R complex were obtained using a pentaerythritol ethoxylate (15/4 EO/OH, PEE 797)-based screening kit (Jena Bioscience, Jena, Germany), while the IL-18-IL-18R-IL-18R ternary complex was crystallized using a polyethylene glycol (PEG) 4000-based screening kit (Jena Bioscience). The crystallization conditions for both complexes were optimized by screening various detergents and additives. Crystallizations with optimized conditions were scaled up using the hanging-drop or sitting-drop vapour-diffusion method with 24-well plates in which 1 ml protein solution and 1 ml precipitant solution were typically mixed with or without 0.5 ml detergent. Crystallization drops of the IL-18-IL-18R complex were immediately equilibrated with 500 ml precipitant solution. Crystallization of the IL-18-IL-18R-IL-18R complex required a dehydration step prior to vapour diffusion, in which the crystallization drops were air-dried for 6 h at 293 K and subsequently placed over reservoir chambers filled with 200 ml of each precipitant solution. Crystallization plates were incubated under protection from light at 277 K for IL-18 and IL-18-IL-18R-IL-18R or 293 K for IL-18-IL-18R. The final conditions are summarized in Table 2 . or 20%(w/v) glucose (IL-18-IL-18R). X-ray diffraction data sets were collected at 100 K using the synchrotron beamlines at SPring-8, Harima, Japan or Photon Factory (PF), Tsukuba, Japan. The intensity data were processed using XDS (Kabsch, 2010) and SCALA (Evans, 2006) or HKL-2000 software (Otwinowski & Minor, 1997) . When the XDS and SCALA software were used, the space group was determined using POINTLESS (Evans, 2006) . The crystallographic datacollection statistics for IL-18, IL-18-IL-18R and IL-18-IL-18R-IL-18R are summarized in Table 3 . For the IL-18-IL-18R crystals, the statistics with three detergents NDSB-201 (Merck, Whitehouse Station, New Jersey, USA), LysoFos Choline Ether 10 (Affymetrix, Santa Clara, California, USA) and LysoFos Choline 10 (Affymetrix) are shown to indicate the improvement in the data quality.
X-ray diffraction data collection and processing

Results and discussion
Reconstitution of the extracellular IL-18 signalling complex
We previously established a bacterial overexpression and purification system for IL-18 . For structural analysis of the IL-18-mediated signalling complexes, we used a baculovirus expression system to obtain sufficient amounts of the IL-18R and IL-18R receptors for crystallization experiments. Each receptor expressed from Sf9 cells was purified by three chromatographic steps: ionexchange, metal-affinity and gel-filtration chromatography using Q and SP Sepharose, Ni-NTA agarose (Figs. 1a and 1b) and Superdex 75 26/60 ( Figs. 1c and 1d ). Finally, $4 mg IL-18R and $1 mg IL-18R protein with a purity greater than 90% were obtained from 1 l Sf9 cell culture ( Figs. 1c and 1d) , while $5 mg of IL-18 was obtained from 1 l E. coli culture. To form the binary and ternary complexes, purified IL-18, IL-18R and IL-18R were mixed and loaded onto a Superdex 200 16/60 column and each complex was isocratically eluted as a single peak (Fig. 1e) .
The IL-18 ternary complex was previously reported to assemble in a hierarchical order . We confirmed this finding and its stoichiometry using analytical gel-filtration column chromatography with purified recombinant proteins. Formation of a ternary complex (MW 119.5 kDa) with 1:1:1 stoichiometry was clearly observed (Fig. 2a ). In the absence of IL-18R (MW 51.5 kDa), IL-18R (MW 61.4 kDa) and IL-18 (MW 18.6 kDa) co-eluted as a complex with an estimated molecular mass of 70.0 kDa, suggesting stable 1:1 complex formation (Fig. 2a) . In contrast, the IL-18R receptor did not show complex formation with IL-18R or IL-18 alone (Figs. 2b and 2c) . Thus, our data clearly demonstrate that the IL-18-IL-18R binary complex is required for the binding of IL-18R. Both the IL-18-IL-18R and IL-18-IL-18R-IL-18R complexes were subjected to crystallization screening.
Crystallization and preliminary crystallographic analysis
Optimized crystallization conditions are summarized in Table 2 . Single crystals of IL-18 with typical dimensions of 200 Â 200 Â 200 mm (maximum dimensions 300 Â 300 Â 300 mm) appeared within one week at 277 K (Fig. 3a) . Crystals of IL-18-IL-18R were obtained with various detergents as indicated in Table 2 . Spherical moss-like crystals were initially obtained, but three single-crystal forms appeared in the presence of different detergents within a few days at 293 K; these detergents were NDSB-201 (Fig. 3b) , LysoFos Choline Ether 10 ( Fig. 3c) and LysoFos Choline 10 ( Fig. 3d) . A single crystal of IL-18-IL-18R-IL-18R with dimensions of 50 Â 50 Â 300 mm appeared within a few weeks at 277 K (Fig. 3e) .
Crystals of IL-18 diffracted to 2.33 Å resolution and belonged to space group P2 1 , with unit-cell parameters a = 68.15, b = 79.51, c = 73.46 Å , = 100.97 . The IL-18-IL-18R complex crystals obtained with NDSB-201 or LysoFos Choline Ether 10 diffracted to 3.90 and 3.30 Å resolution, respectively, and a complete data set was collected for each. Of the three crystal forms, the crystal obtained with LysoFos Choline 10 yielded a complete data set at the highest resolution, 3.10 Å , and belonged to space group P2 1 2 1 2, with unit-cell parameters a = 135.49, b = 174.81, c = 183.40 Å . The crystal of the IL-18-IL-18R-IL-18R complex diffracted to 3.10 Å resolution and belonged to space group P2 1 2 1 2 1 , with unit-cell parameters a = 72.56, b = 111.56, c = 134.57 Å . Crystallographic data and X-ray datacollection statistics are summarized in Table 3 . Further structural determination is in progress.
X-ray data collection was supported by SPring-8 (Harima, Japan), the Photon Factory (Tsukuba, Japan) and the Platform for Drug Discovery, Informatics and Structural Life Science (Japan). We thank T. Tsunaka (Kyoto University) for his support in the use of beamline Figure 2 Gel-filtration profiles for recombinant IL-18, IL-18R and IL-18R and their mixtures in all possible combinations. IL-18 and its receptors were mixed at the ratios indicated. (a) The typical trace for the binary IL-18-IL-18R complex (orange) and ternary IL-18-IL-18R-IL-18R complex (black). (b) The elution profile for a 1:1 mixture of IL-18R and IL-18R (purple) overlaid with that for each receptor alone (red or blue). (c) The IL-18 and IL-18R mixture (green) eluted in two separated peaks. (d) The elution volumes for IL-18, IL-18R, IL-18R and its complexes were plotted against the calibration line. (e) A summary of the deduced molecular weights.
